$KALV KalVista Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in KalVista Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in KalVista Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in KalVista Pharmaceuticals, Inc. for free.
CIK Number: 0001348911
IRS Number: 200915291
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KALV
Company Address: 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE 02142
Phone number: 650-855-6777
Former name: Carbylan Biosurgery Inc, date of change: 2006-01-05
Former name: Carbylan Therapeutics, Inc., date of change: 2014-09-16
Prev close: $0.68
Average Daily Volume: 420,723
Days Low: $0.00
Year Low: $0.44
Year High: $4.14
KalVista Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | A | 25.95 | 25,000 | 648,750 | 25,000 | |
May 06 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 24.84 | 5,000 | 124,197 | 42,969 | 48 K to 43 K (-10.42 %) |
May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | M | 10.21 | 6,000 | 61,260 | 20,255 | |
May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 24.84 | 6,000 | 149,051 | 54,234 | 60.2 K to 54.2 K (-9.96 %) |
May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Buy | M | 10.21 | 6,000 | 61,260 | 60,234 | 54.2 K to 60.2 K (+11.06 %) |
May 04 2021 | KALV | KalVista Pharmaceu ... | Audhya Paul K. | Chief Medical Offic ... | Option Exercise | A | 24.97 | 100,000 | 2,497,000 | 100,000 | |
Apr 30 2021 | KALV | KalVista Pharmaceu ... | Smith Michael David | Senior VP, Developm ... | Option Exercise | M | 8.39 | 10,014 | 84,017 | 30,096 | |
Apr 30 2021 | KALV | KalVista Pharmaceu ... | Smith Michael David | Senior VP, Developm ... | Sell | S | 25.76 | 10,014 | 257,983 | 0 | 10 K to 0 (-100.00 %) |
Apr 30 2021 | KALV | KalVista Pharmaceu ... | Smith Michael David | Senior VP, Developm ... | Buy | M | 8.39 | 10,014 | 84,017 | 10,014 | 0 to 10 K |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | M | 16.08 | 13,368 | 214,957 | 7,332 | |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | M | 8.21 | 14,662 | 120,375 | 6,038 | |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | M | 7.91 | 12,856 | 101,691 | 0 | |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | M | 7.91 | 36,127 | 285,765 | 12,856 | |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Option Exercise | M | 7.91 | 11,017 | 87,144 | 48,983 | |
Apr 29 2021 | KALV | KalVista Pharmaceu ... | Maetzel Andreas | Senior Vice Preside ... | Sell | S | 25.04 | 40,886 | 1,023,589 | 0 | 40.9 K to 0 (-100.00 %) |
View all KalVista Pharmaceuticals, Inc. insider transactions.